Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Zelira Therapeutics ( (AU:ZLD) ) has provided an announcement.
Zelira Therapeutics Limited has announced the quotation of 550,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code ZLD. This move is part of a previously announced transaction, potentially enhancing the company’s market presence and providing additional capital for its operations, which could impact its positioning in the pharmaceutical industry.
More about Zelira Therapeutics
Zelira Therapeutics Limited operates in the pharmaceutical industry, focusing on the development and commercialization of cannabinoid-based medicines. The company targets a range of therapeutic areas, aiming to leverage the potential benefits of cannabinoids in treating various medical conditions.
YTD Price Performance: -21.32%
Average Trading Volume: 275
Technical Sentiment Signal: Buy
Current Market Cap: $3.4M
For an in-depth examination of ZLD stock, go to TipRanks’ Stock Analysis page.